|
|
Reference
|
|
1  
|
Chawla, M., Betcherman, G., Banerji, A. (2007) From Red to Gray. World Bank
|
|
 
|
Dagović, A., Žugić, A., Jakovljević, M.B. (2015) Macroeconomic policy impact on oncology-related public expenditure in an emerging European market: Signs of early recovery. Serbian Journal of Experimental and Clinical Research, vol. 16, br. 1, str. 43-50
|
|
|
Ess, S.M., Schneeweiss, S., Szucs, T.D. (2003) European healthcare policies for controlling drug expenditure. Pharmacoeconomics, 21: 89-103
|
|
2
|
Gajić-Stevanović, M., Teodorović, N., Dimitrijević, S., Jovanović, D. (2010) Ispitivanje finansijskih tokova u zdravstvenom sistemu Republike Srbije u periodu od 2003. do 2006. godine. Vojnosanitetski pregled, vol. 67, br. 5, str. 397-402
|
|
|
Getzen, T.E. (1992) Population Aging and the Growth of Health Expenditures. Journal of Gerontology, 47(3): S98-S104
|
|
3
|
Jakovljevic, M.B. (2013) Resource allocation strategies in Southeastern European health policy. Eur J Health Econ., 14: 153-9
|
|
1
|
Jakovljevic, M.B. (2014) Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market. Farmeconomia. Health economics and therapeutic pathways, 15(1): 27
|
|
1
|
Jakovljevic, M.B., Lazic, Z., Verhaeghe, N., Jankovic, S., Gajovic, O., Annemans, L. (2013) Direct medical costs of COPD diagnosis and treatment, Eastern vs Western European country - examples of Serbia and Belgium. Farmeconomia. Health economics and therapeutic pathways, 14(4): 161
|
|
|
Jakovljevic, M., Cupurdija, V., Lazic, Z. (2012) Cost of illness of community-acquired pneumonia. Review of the literature and possible strategies in the Serbian health care setting. Farmeconomia. Health economics and therapeutic pathways, 13(3): 133
|
|
1 
|
Jakovljevic, M.B., Nakazono, S., Ogura, S. (2014) Contemporary generic market in Japan - key conditions to successful evolution. Expert Review of Pharmacoeconomics & Outcomes Research, 14(2): 181-194
|
|
|
Jakovljević, M., Mijailović, Z., Popovska, J.B., Canović, P., Gajović, O., Jovanović M (2013) Assessment of Viral Genotype Impact to the Cost-Effectiveness and Overall Costs of Care for Peg-Interferon-2α + Ribavirine Treated Chronic Hepatitis C Patients. Hepatitis Monthly, 13(6):
|
|
1 
|
Jakovljević, M., Varjačić, M., Janković, S.M. (2008) Cost-effectiveness of ritodrine and fenoterol for treatment of preterm labor in a low-middle-income country: A case study. Value in Health, vol. 11, br. 2, str. 149-153
|
|
8
|
Jakovljević, M., Jovanović, M., Lazić, Z., Jakovljević, V., Đukić, A., Velicković, R., Antunović, M. (2011) Current efforts and proposals to reduce healthcare costs in Serbia. Serbian Journal of Experimental and Clinical Research, vol. 12, br. 4, str. 161-163
|
|
1
|
Jakovljević, M., Ranković, A., Rančić, N., Jovanović, M., Ivanović, M., Gajović, O., Lazić, Z. (2013) Radiology Services Costs and Utilization Patterns Estimates in Southeastern Europe-A Retrospective Analysis from Serbia. Value in Health Regional Issues, 2(2): 218-225
|
|
3
|
Jakovljević, M.B. (2014) The key role of the leading emerging BRIC markets in the future of global health care. Serbian Journal of Experimental and Clinical Research, vol. 15, br. 3, str. 139-143
|
|
2
|
Jovanović, M., Jakovljević, M. (2011) Inpatient detoxification procedure and facilities: Financing considerations from an Eastern European perspective. Alcohol Alcohol, 44, str. 547-54
|
|
|
Kovačević, A.M., Rančić, N.K., Tarabar, D.K., Dragojević-Simić, V.M. (2014) Targeted therapy and its availability in Serbia. Hospital Pharmacology - International Multidisciplinary Journal, vol. 1, br. 2, str. 93-101
|
|
1
|
Kovačević, A., Dragojević-Simić, V., Rančić, N., Jurišević, M., Gutzwiller, F., Matter-Walstra, K., Jakovljević, M. (2015) End-of-life costs of medical care for advanced stage cancer patients. Vojnosanitetski pregled, vol. 72, br. 4, str. 334-341
|
|
1
|
Liu, G.G., Zhao, Z., Cai, R., Yamada, T., Yamada, T. (2002) Equity in health care access to: assessing the urban health insurance reform in China. Social Science & Medicine, 55(10): 1779-1794
|
|
1
|
Majstorović, B.M., Milaković, B.D., Marković, S.Z., Mijajlović, M.S., Kastratović, D.A. (2014) The results and methodological concerns about pharmaco-economic evaluation in anesthesia. Hospital Pharmacology - International Multidisciplinary Journal, vol. 1, br. 2, str. 68-75
|
|
|
Malý, I., Kostadinova, T., Nemec, J., Setnikar, C.S., Darmopilova, Z. (2013) Financing health care: What can we learn from CEE experience?. Administrative Culture, 14, 212-237
|
|
|
Mcleod, L., Bereza, B.G., Shim, M., Grootendorst, P. (2011) Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data. Open Med., 5: 1-9
|
|
1
|
Murata, C., Yamada, T., Chen, C., Ojima, T., Hirai, H., Kondo, K. (2010) Barriers to Health Care among the Elderly in Japan. International Journal of Environmental Research and Public Health, 7(4): 1330-1341
|
|
|
Tambor, M., Pavlova, M., Rechel, B., Golinowska, S., Sowada, C., Groot, W. (2013) The inability to pay for health services in Central and Eastern Europe: evidence from six countries. European Journal of Public Health, 24(3): 378-385
|
|
2
|
Vuković, M., Gvozdenović, B.S., Gajić, T., Stamatović, G.B., Jakovljević, M., McCormick, B.P. (2012) Validation of a patient satisfaction questionnaire in primary health care. Public Health, 126(8): 710-718
|
|
|
World Health Organization Global health expenditure database: NHA indicators. Available at: http://apps.who.int/nha/database/Select/Indicators/ en [accessed 10th July 2014]
|
|
|
World Health Organization (2014) European health for all database (HFA-DB). World Health Organization Regional office for Europe, April, http://data.euro.who.int/hfadb/ [10th July 2014]
|
|
6
|
World Health Organization Available at: http://www.who.int/whr/en/ [accessed 10th July 2014]
|
|
|
Yamada, T., Chen, C.C., Yamada, T., Chiu, I.M., Worrall, J.D. (2010) Pharmaceutical price control policy, pharmaceutical innovation, and health durability. Topharmej, 2, 34-46
|
|
|
|
|